PDGFRB and Hepatic fibrosis: Because PDGF and PDGFR-β have been implicated in hepatic fibrosis, many antifibrosis strategies focus on reducing the secretion of PDGF, inhibiting the coupling of PDGF and PDGFR, blocking the MAPK signal transduction pathway to reduce PDGF-induced HSCs proliferation subsequently.